EMOTION: Cognition and Emotion in the SII and IBD

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Completed
CT.gov ID
NCT01095042
Collaborator
French National Society of Gastroenterology (Other), Association François Aupetit (Other)
120
1
2
55
2.2

Study Details

Study Description

Brief Summary

The study aims at showing that the susceptibility in the stress is more raised at the person affected digestive pathologies (SII or IBD) in forgiveness than healthy subjects.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: emotion
N/A

Detailed Description

The objective of the study which we wish to lead consists in looking for, at the patients SII and IBD in forgiveness, the existence of a correlation between the rate of cortisol(Hormone of the stress) and the level of HRV (Heart Rate Variability) to estimate the inhibitive fronto-amygdalien tonus.

So we make the hypothesis that the persons affected by digestive pathologies of type SII or IBD would present an emotional and physiological vulnerability more important than unhurt subjects of pathologies.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Etude de la réactivité émotionnelle Des Patients MICI ou SII
Study Start Date :
Oct 1, 2008
Actual Primary Completion Date :
May 1, 2013
Actual Study Completion Date :
May 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control group

30 Asymptomatic Healthy Volunteers Intervention : Observation of emotional behavior in asymptomatic healthy volunteers subjected to stress.

Behavioral: emotion
Show that the susceptibility in the stress (recording of Heart Rate Variability;viewing films;...) is more important at the person affected by digestive pathologies (SII or IBD) in forgiveness than to unhurt subjects of pathologies.
Other Names:
  • STRESS
  • Experimental: Experimental group

    Persons reached by digestive pathologies (SII or IBD). Group SII : 30 patients Group IBD: 60 patients (30 patients RCH and 30 patients CD) Intervention : Observation of emotional behavior in person affected by digestive pathologies subjected to stress.

    Behavioral: emotion
    Show that the susceptibility in the stress (recording of Heart Rate Variability;viewing films;...) is more important at the person affected by digestive pathologies (SII or IBD) in forgiveness than to unhurt subjects of pathologies.
    Other Names:
  • STRESS
  • Outcome Measures

    Primary Outcome Measures

    1. RATE PLASMATIQUE OF CORTISOL COUPLED WITH THE CARDIAC VARIABILITY [24 MONTHS]

    Secondary Outcome Measures

    1. SCORES OF DEPRESSIVE SYMPTOMATOLOGIE AND ANXIETY, RATE PLASMATIQUES OF CATECHOLAMINES, LEPTINE, ADIPONECTINE AND PRO-INFLAMMATORY CYTOKINES. [24 MONTHS]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with SII :Membership to the Social Security,SII defined according to the criteria Rome III.

    • Patients with IBD :Membership to the Social Security,patients with a ulcerative colitis(UC) or a Crohn's disease (CD)ileal and/or colic.

    Exclusion Criteria:
    • Existence of a severe affectation on the general plan (cardiac,respiratory,hematological,renal,hepatic,cancerous),

    • Subject diabetic,

    • Pregnant or breast-feeding woman,

    • Subject included in another clinical and\or therapeutic trial or having been included in a clinical and\or therapeutic trial for less than a month,

    • Subject presenting a psychiatric pathology evident,

    • Person under guardianship.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hôpital Michallon-CHU Grenoble Grenoble France 38000

    Sponsors and Collaborators

    • University Hospital, Grenoble
    • French National Society of Gastroenterology
    • Association François Aupetit

    Investigators

    • Principal Investigator: Bruno Bonaz, MD-PhD,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital, Grenoble
    ClinicalTrials.gov Identifier:
    NCT01095042
    Other Study ID Numbers:
    • 0817
    • 2008-A00994-51
    First Posted:
    Mar 29, 2010
    Last Update Posted:
    Jan 28, 2014
    Last Verified:
    Jan 1, 2014
    Keywords provided by University Hospital, Grenoble
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 28, 2014